Introduction
============

Intraductal papillary neoplasms of the bile duct (IPNBs) are recognized as a distinct type of biliary tumor ([@b1-mco-0-0-1139],[@b2-mco-0-0-1139]). This entity includes previous categories, such as biliary papillomatosis and mucin-producing bile duct tumors ([@b3-mco-0-0-1139]). IPNBs share clinicopathological characteristics with intraductal papillary mucinous neoplasms (IPMNs) of the pancreas, as they both typically present with dilatation of the affected ducts, predominantly intraductal papillary masses and the overproduction of mucin ([@b3-mco-0-0-1139],[@b4-mco-0-0-1139]). The development of multiple separate tumors is a characteristic feature potentially associated with either condition. An index report of IPNBs included a case of multiple IPNBs, in which three separate tumors developed in the intrapancreatic bile duct 6 years after the initial tumor in the cystic duct was resected ([@b1-mco-0-0-1139]). However, multiple IPNBs have only been described in a small number of reports, suggesting that a presentation with multiple biliary tumors is less common compared with pancreatic IPMNs. The rarity of multiple IPNBs has restricted the discussion on clinicopathological characteristics and developmental mechanisms.

We herein describe another case of metachronous multiple IPNBs and review the literature in order to establish whether these cases represent true multicentric tumors or intrabiliary tumor dissemination.

Case report
===========

A 64-year-old woman with no particular previous medical history presented with fever lasting for 1 week. No remarkable findings were noted in a physical examination. The serological tests revealed elevated levels of C-reactive protein (13.4 mg/dl; normal range, \<0.5 mg/dl), alanine aminotransferase (62 IU/l; normal range, 5--36 IU/l), alkaline phosphatase (816 IU/l; normal range, 110--370 IU/l) and γ-glutamyl transpeptidase (360 IU/l; normal range, 9--50 IU/l). The leukocyte count and serum levels of aspartate aminotransferase, total bilirubin, carcinoembryonic antigen and carbohydrate antigen 19--9 were within the normal range. On computed tomography (CT), a 75-mm cystic mass in the right hepatic lobe and dilatation of the intrahepatic bile duct were detected ([Fig. 1A](#f1-mco-0-0-1139){ref-type="fig"}). Following aspiration due to a suspected infectious liver cyst, the patient underwent endoscopic retrograde cholangiography (ERC), which revealed filling defects within the dilated common hepatic duct ([Fig. 1B](#f1-mco-0-0-1139){ref-type="fig"}). On peroral cholangioscopy (POCS), a papillary mucin-producing tumor was identified around the orifice of the right hepatic duct, while no obvious tumor was present in the left hepatic and common bile ducts ([Fig. 2](#f2-mco-0-0-1139){ref-type="fig"}). Although the small bile duct biopsy from the papillary tumor was not conclusive, extended right hepatectomy was performed for suspected IPNB. On intraoperative frozen section examination, the common hepatic duct margin was tumor-free, while the left hepatic duct appeared to be positive for an intraepithelial tumor with high-grade dysplasia. Despite additional resection of the left hepatic duct, the final resection margin remained focally positive for an intraepithelial neoplasm.

On macroscopic examination, the main tumor was located in the right hepatic duct and exhibited mucin overproduction. The tumor also extended into the dilated intrahepatic bile ducts. Microscopically, the biliary neoplasm consisted of atypical epithelial cells arranged in a high papillary architecture along thin fibrovascular stalks ([Fig. 3](#f3-mco-0-0-1139){ref-type="fig"}). The tumor cells exhibited intestinal-type morphology (e.g., nuclear stratification and goblet cells), with enlarged nuclei and loss of polarity, characteristics consistent with high-grade dysplasia. No invasive growth was observed. On immunostaining, the cells were diffusely positive for mucin core protein (MUC)2 and MUC5AC ([Fig. 3](#f3-mco-0-0-1139){ref-type="fig"}), focally positive for MUC1, MUC6 and cytokeratin (CK)20, and negative for CK7. Based on the histological findings, the tumor was diagnosed as intestinal-type IPNB with high-grade dysplasia. Since the left hepatic duct margin was positive for tumor cells, gemcitabine 1,000 mg/m^2^ was administered every 2 weeks for a total of 15 courses.

Twenty-six months later, the patient underwent a follow-up CT, which revealed no recurrence in the left hepatic duct, but detected a papillary tumor in the common bile duct ([Fig. 4A](#f4-mco-0-0-1139){ref-type="fig"}). On ERC, the tumor appeared to be a mucin-producing neoplasm with abundant mucus secreted from the dilated ampulla of Vater ([Fig. 4B](#f4-mco-0-0-1139){ref-type="fig"}). Pancreatoduodenectomy was thus performed for suspected recurrent IPNB. In the resected specimen, the tumor was located in the lower common bile duct ([Fig. 5](#f5-mco-0-0-1139){ref-type="fig"}). The histological appearance of the tumor was nearly identical to that of the original neoplasm, with a similar immunohistochemical phenotype ([Fig. 5](#f5-mco-0-0-1139){ref-type="fig"}). No invasive cancer was found. The tumor was surrounded by non-neoplastic epithelium. The postoperative course was uneventful, with no signs of recurrence at the time of writing of this manuscript (follow-up of 12 months).

Verbal consent for publication of the case details was obtained from the patient.

Discussion
==========

In the present case, two separate IPNBs developed over a \~2-year period. Although the left hepatic duct margin in the initial surgery was focally positive for intraepithelial neoplasia, the second tumor developed in the lower common bile duct. The recurrent tumor was surrounded by non-neoplastic epithelium, suggesting that the two IPNBs were separate, with no tumor cells between them. This case was originally considered to be multicentric IPNBs. However, we also hypothesized that the second tumor represented intrabiliary tumor dissemination, as both tumors had a nearly identical histological appearance, and the second tumor developed in the lower part of the bile duct compared with the primary tumor. Since intrabiliary dissemination is not considered as progression in IPNBs, a literature review was performed to investigate this possibility.

Large studies were first reviewed, in which \>20 cases of IPNBs were investigated, in terms of how often multiple tumors develop in patients with IPNBs. Among \~10 large studies reported to date from Asia, Europe and the USA, two provided detailed descriptions of patients with multiple biliary tumors ([@b5-mco-0-0-1139],[@b6-mco-0-0-1139]). In a study by Paik *et al* ([@b5-mco-0-0-1139]), 4 of the 25 investigated cases with IPNBs were found to have tumor recurrence after complete resection with negative surgical margins. Two patients had recurrence in the liver parenchyma and lymph nodes, representing remote metastasis of the invasive components. In the remaining 2 patients, the primary IPNBs were located in the intrahepatic bile ducts, whereas the recurrent tumors developed in the distal bile duct, similar to our patient. Kang *et al* ([@b6-mco-0-0-1139]) also reported multifocal tumors in 43 of 84 (51%) patients with IPNBs; however, this number appears to be markedly higher compared with that in other studies, which leads us to question the definition of multiple IPNBs used in that study. No or limited information was available in terms of multiple tumors in the remaining studies ([@b7-mco-0-0-1139]--[@b10-mco-0-0-1139]).

An additional literature review was conducted with a focus on case reports. The PubMed database was searched using the terms 'IPNB', 'mucin-producing bile duct tumor', 'biliary papillomatosis', 'multiple', 'multiplicity' and 'recurrence', and the selected manuscripts were reviewed. A similar search was also conducted through ICHUSHI (<http://login.jamas.or.jp/>), which enables searching for medical literature and abstracts written in Japanese. Cases of recurrent tumors at the anastomotic site were excluded, as they were most likely to be local recurrence rather than multiple tumors. A total of 9 additional case reports describing multiple separate IPNBs were eventually retrieved ([@b11-mco-0-0-1139]--[@b19-mco-0-0-1139]). The clinicopathological characteristics of these cases and our patient are summarized in [Table I](#tI-mco-0-0-1139){ref-type="table"}. Of the 10 patients, 8 initially underwent liver resection for IPNBs that developed in the hilar or intrahepatic bile duct, while the remaining 2 received bile duct resection for a cystic duct neoplasm or cholecystectomy for a gallbladder IPNB. Multiple tumors were identified in the original resected specimens in 2 patients (cases 4 and 9, [Table I](#tI-mco-0-0-1139){ref-type="table"}). Recurrence occurred over a median period of 25 months. Recurrent tumors developed in more distal parts of the bile duct compared with the primary tumors in 8 of the 10 patients.

Although the majority of the patients had a single episode of tumor recurrence, 2 patients had multiple episodes (cases 3 and 7 in [Table I](#tI-mco-0-0-1139){ref-type="table"}) ([@b13-mco-0-0-1139],[@b17-mco-0-0-1139]). Miyata *et al* ([@b17-mco-0-0-1139]) described a case that developed recurrent IPNB twice. A 66-year-old woman originally had IPNB in the left hepatic lobe and underwent left hepatectomy with a negative surgical margin. Fifteen months later, a recurrent tumor was detected in the upper common bile duct, which was surgically resected. Although the bile duct margin in the second surgery was also tumor-free, another papillary tumor was detected in the intrapancreatic bile duct 35 months later, requiring the Whipple procedure.

The literature review clearly demonstrated that recurrent tumors typically develop in the lower bile duct compared with the primary IPNBs. Of note, 84% of primary IPNBs develop in the intrahepatic or hilar bile duct ([@b20-mco-0-0-1139]), in contrast to recurrent IPNBs, 80% of which developed in the common bile duct ([Table I](#tI-mco-0-0-1139){ref-type="table"}). These findings suggest that intrabiliary dissemination is a more likely mechanism for multiple IPNBs, rather than true multicentricity in the majority of the patients. However, multicentric IPNBs remain a possibility in a specific proportion of patients, particularly those with risk factors for this biliary neoplasm, such as hepatolithiasis. Future molecular studies comparing gene abnormalities in multiple IPNBs are required to elucidate the frequency of true multicentric IPNBs developing in the biliary tree.

Matsubara *et al* ([@b21-mco-0-0-1139]) recently reported a case of papillary adenocarcinoma of the ampulla of Vater, which was subsequently complicated by retrograde intraductal dissemination in the pancreas. Although this is the only report raising the possibility of cancer cells possibly disseminating along the pancreatobiliary duct system, we have observed similar cases, in which ampullary cancers or intrapancreatic cholangiocarcinomas were intraductally disseminated to the pancreas. To the best of our knowledge, the present study is the first report suggesting that a similar pattern of tumor extension may also occur in the bile duct. Multiple IPMNs, particularly of the branch-duct type, are common; however, the majority are suspected to represent true multicentric tumors. One reason is that the majority of branch-duct type IPMNs are low-grade, with a low propensity for dissemination. Another potential factor is that the pancreatic duct is located horizontally, in contrast to the bile duct, which is positioned vertically.

In conclusion, the results of our case indicate that multiple IPNBs may be attributed to the biliary dissemination of tumor cells. This hypothesis is supported by the literature review. True multicentric IPNBs appear to be less common than initially considered, given that the extrahepatic lower bile duct is typically affected by recurrent IPNBs.
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![Findings on contrast-enhanced computed tomography (CT) and endoscopic retrograde cholangiography (ERC). (A) Contrast-enhanced CT (coronal image) showing a 75-mm cystic mass in the right hepatic lobe and dilatation of the intrahepatic bile duct. (B) ERC showing a filling defect in the common duct (arrow). The cyst is not visible, as it was aspirated prior to ERC.](mco-06-03-0315-g00){#f1-mco-0-0-1139}

![Findings on peroral cholangioscopy. A papillary tumor with a granular surface is observed in the orifice of the right hepatic duct to the common hepatic duct.](mco-06-03-0315-g01){#f2-mco-0-0-1139}

![Histopathological findings of primary intraductal papillary neoplasm of the bile duct. The tumor consists of high-papillary proliferation of the atypical biliary epithelium along delicate fibrovascular stalks \[upper left panel, hematoxylin and eosin (H&E) staining; magnification, ×40\]. The tumor cells displayed elongated nuclei and nuclear stratification, an overall appearance that was consistent with an intestinal-type neoplasm (upper right panel, H&E staining; magnification, ×100). The tumor cells were immunoreactive to mucin core protein (MUC)2 and MUC5AC (lower left and right panels, respectively; magnification, ×100).](mco-06-03-0315-g02){#f3-mco-0-0-1139}

![Contrast-enhanced computed tomography (CT) and endoscopic retrograde cholangiopancreatography showing a recurrent intraductal papillary neoplasm of the bile duct. (A) Contrast-enhanced CT (coronal image) showing a mass lesion in the distal bile duct (arrow). (B) The orifice of the ampulla of Vater is dilated with mucus secretion.](mco-06-03-0315-g03){#f4-mco-0-0-1139}

![Histopathological findings of recurrent intraductal papillary neoplasm of the bile duct. On macroscopic examination, the papillary tumor was located in the lower bile duct (upper left panel). The recurrent tumor exhibited papillary proliferation of intestinal-type atypical cells along thin fibrovascular stalks (upper right panel, hematoxylin and eosin staining; magnification, ×40). The tumor cells were immunoreactive to mucin core protein (MUC)2 and MUC5AC (lower left and right panels, respectively; magnification, ×100). The overall appearance is similar to that of the primary tumor.](mco-06-03-0315-g04){#f5-mco-0-0-1139}

###### 

Reported cases of multiple recurrent intraductal papillary neoplasms of the bile duct.

        Primary tumor        Recurrent tumor                                                                                                                                       
  ----- -------------------- ----------------- --------------------------------------- --------------- --- --------------------------------------- --- --------------------- ----- -----------------------
    1   IHBD (B2/3)          1                 Left hepatectomy                        Negative        1   Lower CBD                               1   Whipple               36    ([@b11-mco-0-0-1139])
    2   Cystic duct to CBD   1                 Choledochectomy and cholecystectomy     Negative        1   Lower CBD                               3   Whipple               57    ([@b12-mco-0-0-1139])
    3   IHBD (B4)            1                 Left hepatectomy                        Negative        4   IHBD (B1)                               1   Laser ablation          6   ([@b13-mco-0-0-1139])
                                                                                                           Upper CBD                               1   Enucleation             7   
                                                                                                           RHD                                     1   Choledochectomy       28    
                                                                                                           IHBD (right posterior segmental duct)   1   Laser ablation          2   
    4   IHBD (B2/3)          2                 Left hepatectomy                        Not described   1   Lower CBD                               1   Whipple               24    ([@b14-mco-0-0-1139])
    5   RHD                  1                 Left hepatectomy and choledochectomy    Negative        1   Lower CBD                               1   Whipple               48    ([@b15-mco-0-0-1139])
    6   Gallbladder          1                 Cholecystectomy                         Negative        1   Lower CBD                               3   Whipple               10    ([@b16-mco-0-0-1139])
    7   IHBD (B2)            1                 Left hepatectomy                        Negative        2   Upper CBD                               1   Choledochectomy       15    ([@b17-mco-0-0-1139])
                                                                                                           Lower CBD                               1   Whipple               35    
    8   IHBD (B8)            1                 Right hepatectomy and choledochectomy   Negative        1   Lower CBD                               1   Whipple               16    ([@b18-mco-0-0-1139])
    9   LHD                  2                 Left hepatectomy                        Negative        1   IHBD (right lobe)                       1   Drainage stent only   29    ([@b19-mco-0-0-1139])
  10    RHD                  1                 Right hepatectomy                       Positive        1   Lower CBD                               1   Whipple               26    Present
